SlideShare a Scribd company logo
1 of 1
Download to read offline
FDG PET/CT Utility in Gynecologic Malignancies: A comprehensive review of
                                                                      anatomy, pathways of metastatic spread and scan findings
                                                                               Nicholas Plaxton, MD1 , Aruna Polsani, MD1, Raghuveer Halkar, MD1, Karen Godette, MD1 , Barron, Bruce, MD1,2
                                                                                               1Emory University School of Medicine, 2 Atlanta Veterans Affairs Medical Center




LEARNING OBJECTIVES                                                               PELVIC ANATOMY                                                                                     CERVICAL                                                              OVARIAN                                       ENDOMETRIAL                                               VAGINAL
                                                                                                       Uterine fundus                                               • 150,000 Deaths annually                                             • 2nd most common gynecological cancer
1. Pictorial review of clinical features of major                                                                                                                                                                                                                                               • Most common gynecological cancer                  • Cervical cancer extension or recurrence into
                                                                                                                                       Fallopian tube                    4000 in US                                                      • Most common death from gynecologic cancer
   gynecologic cancers including cervical,                                                                                                                                                                                                                                                      • 142,000 women per year                            the vagina is most common tumor
   ovarian, endometrial, vaginal, and vulvar
                                                                                                                                           Infundibulum
                                                                                                                                            Fimbria                      11,000 new cases in US                                          • 22,000 new cases and 14,000 deaths in US            • 4TH most common malignancy in US women            • Primary vaginal cancer is less than 3% of all
                                                                                                                                         Ovary
                                                                                                                                                                    • PET/CT is more accurate in assessing nodal                          • Nonspecific symptoms – bloating, distention
   malignancies and demonstrate the role of                                       Uterine Body                                                                                                                                                                                                  • Most cases in post menopause                      gynecological malignancies
                                                                                                                        Ascending branch of uterine artery
                                                                                                                                                                    spread than CT and MRI (sensitivity 89% vs 39%)                       • 75 % present with stage III or IV disease
   FDG PET/CT.                                                                                                                      Internal iliac                                                                                                                                              • Highest incidence in 7TH decade of life           • Squamous type (HPV , 60 – 80 yrs)
                                                                                                                                    artery
                                                                                                                                                                    • SUV negatively correlates to treatment response                     • Residual tumor > 2cm survival of 12-16 months       • Abnormal uterine bleeding common symptom          • Adenocarcinoma type ( DES use, 12 – 30 yrs)
                                                                                                    Cervix                           Uterine artery
                                                                                            External Os                                                             • Positive PET has positive predictive value of 90%                   • Tumor < 2 cm survival is 40-45 months
2. Illustrate and correlate anatomic and                                                                                    Vaginal branch of uterine artery
                                                                                                                                                                                                                                                                                                • 5 year survival 80%                               • Lymphatic spread in distal 1/3 to inguinal nodes
                                                                                     Vaginal canal                                                                  • PET has high rate of false negatives                                • Debulking surgery is mainstay of treatment
   conventional imaging features of                                                                                                                                                                                                                                                             • Dependent on stage, myometrial involvement        • Lymphatic spread in proximal 2/3 to pelvic and
                                                                                                                                                                    • Limited sensitivity in early stage IA and IIA                       • Preoperative imaging achieves optimal debulking
   gynecologic malignancies.                                                                                                                                                                                                                                                                    and histological type                               para-arotic nodes (PALN)
                                                                                                                                                                    • Try to minimize urine FDG activity (Foley, voiding)                 • PET improves accuracy in staging
                                                                                                      Coronal Illustration                                                                                                                                                                      • Poor prognosis in advanced or recurrent disease
                                                                                                                                                                    • Primary spread of tumor via lymph node paths                        • Staging concordant with clinical pathology in 69%
3. Demonstrate the integration of FIGO                                                                                                                                 1.   obturator, internal iliac, external iliac, and common iliac
                                                                                                                                                                                                                                                                                                • Lymphatic spread to pelvic or para-arotic nodes
   scoring and treatment planning to improve                                                                                                                           2.   direct to common iliac
                                                                                                                                                                                                                                          for PET vs. 53% for CT                                • Hematogenous spread to lung, liver, bones or
   accuracy of staging.                                                                                                                                                3.   common iliac, pre-sacral and para-arotic                      • Mucinous type represents 12-15% of ovarian          vagina
                                                                                                                                  Perimetrium                       • Inguinal /axillary nodes reactive in HIV, not mets                  cancers and usual is not FDG avid
      INTRODUCTION                                                                                                                Myometrium

                                                                                                                                  Rectouterine pouch
                                                                                                                                                                    • Liver metastasis in a third of recurrent disease                    • Ovarian cancer tends to spread via peritoneal
                                                                                                                                                                                                                                                                                                                                                    Vaginal metastasis before and after treatment
                                                                                          Cervix                                  of Douglas
In the United States in 2007,* 80,976 women                                          Fundus
                                                                                                                                  Endometrium
                                                                                        Body
were diagnosed with gynecologic cancer, and
27,739 succumbed to the disease. Our                                                                                             Vesicouterine pouch
                                                                                                                                 of Meiring

objective was to review the five major
gynecologic cancers (cervical, ovarian,                                                                                                                                                                                                                                                                        Primary uterine cancer
                                                                                                   T2 Weighted MRI pelvis                                                                                                                 Virchow’s Node
uterine, vaginal, and vulvar) and demonstrate
the role of FDG PET/CT in diagnosis,
surveillance, FIGO staging and treatment                                                                                                                           Cervical cancer with pyometra                                                                    Bilateral Ovarian Cancer                                                         Vaginal melanoma               Vaginal cancer
strategy. We selected FDG PET/CT cases
done at Emory University with strong key
                                                                          Right ovary
                                                                          with cysts                                                        Left ovary
                                                                                                                                                                                                                                                                                                                                                                     VULVAR
                                                                                                                                           Internal iliac artery
                                                                                                                                                                                                                                                                                                                                                    • 4% all women genital cancers originate in vulva
                                                                         Right internal
representative findings for each of these                                iliac artery                                                      Left iliacus muscle

gynecological cancers for presentation.                                                                                                                                                                                                                                                                                                             • 2/100,000 women per year
                                                                                                                                           Psoas muscle
                                                                                                                                                                                                                                                                                                  Endometrial cancer with malignant effusion        • 40-60% in premenopause associated with HPV
Understanding       of   key     findings    in
gynecological malignancies is crucial for early                                                                                                                                                                                                                                                                                                     • HPV negative more common in post-menopausal
diagnosis, treatment strategy and assessment                                                                                                                                                                                                                                                                                                        • Growth and infiltration with direct involvement of
of treatment response.                                                                                                                                                                                                                                                                                                                              the vagina, urethra, perineum, and /or anus
                                                                                  Upper pelvis axial CT with contrast
                                                                                                                                                                                                                                                                                                                                                    • Lymphatic spread to inguinal and femoral nodes
             CONTACT                                                                                                                                                                                                                      Sister Mary      Peritoneal Caking                                                                        • 1-7% involve Bartholin’s gland
                                                                                                                                                                   Solitary              Cervical cancer with                             Joseph node                                                                                               • FIGO changes based on invasion and size and
  Nicholas A. Plaxton M.D.                                                                                                                                         hepatic               obstructed os                                                                                                                                              the number of involved lymph nodes
  Depart of Radiology and Imaging Sciences                                                                                               External iliac artery     metastasis                                                                                                                                                                       • FDG PET sens and spec of 80 and 90%
  Division of Nuclear Medicine                                                                                                                                                                                                                                                                                                                      • More accurate in detecting extranodal metastases
                                                                                                                                       Round ligaments
  Email: nickplaxton@emory.edu                                                                                                                                                                                                                                                                    Planning Target Volume for
  Phone: 404 712 4868                                                                                                                  External iliac vein
                                                                                                                                                                                                                                                                                                  radiation treatment
                                                                                                                                       Bladder

References and FIGO classification available                                                                                           Uterus


upon request.
Thanks to Eric Jablonowski for illustration.                                         Lower pelvis axial CT with contrast
           Poster Design & Printing by Genigraphics® - 800.790.4001
                                                                                                                                                                   Cervical cancer with HIV and lymphadenapathy                           Peritoneal Implants                                    Endometrial cancer with multiple metastases         Vulvar cancer

More Related Content

What's hot

Uterine cancer
Uterine cancerUterine cancer
Uterine cancerNaz Kasim
 
4 u1.0-b978-1-4160-6643-9..00193-4..docpdf
4 u1.0-b978-1-4160-6643-9..00193-4..docpdf4 u1.0-b978-1-4160-6643-9..00193-4..docpdf
4 u1.0-b978-1-4160-6643-9..00193-4..docpdfLoveis1able Khumpuangdee
 
He 210 ol power point presentation #1
He 210 ol power point presentation #1He 210 ol power point presentation #1
He 210 ol power point presentation #1Lbitofheaven
 
Phyllodes Tumors: What is the Best Therapeutic Option?_ Crimson Publishers
Phyllodes Tumors: What is the Best Therapeutic Option?_ Crimson PublishersPhyllodes Tumors: What is the Best Therapeutic Option?_ Crimson Publishers
Phyllodes Tumors: What is the Best Therapeutic Option?_ Crimson PublishersCrimsonpublishers-IGRWH
 
Nulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies editedNulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies editedManinder Ahuja
 
Malignant Ovarian Tumors Dr H.K.Cheema Professor OBG,PIMS, Jalandhar
Malignant Ovarian Tumors  Dr H.K.Cheema Professor OBG,PIMS, JalandharMalignant Ovarian Tumors  Dr H.K.Cheema Professor OBG,PIMS, Jalandhar
Malignant Ovarian Tumors Dr H.K.Cheema Professor OBG,PIMS, JalandharDr H.K. Cheema
 
Lecture 1 Pathology: Cervix pdf
Lecture  1 Pathology: Cervix pdfLecture  1 Pathology: Cervix pdf
Lecture 1 Pathology: Cervix pdfRupinderKaur866402
 
UTERINE LEIOMYOSARCOMA
UTERINE LEIOMYOSARCOMAUTERINE LEIOMYOSARCOMA
UTERINE LEIOMYOSARCOMApaviarun
 
carcinoma cervix -update
carcinoma cervix -updatecarcinoma cervix -update
carcinoma cervix -updateMUNEER khalam
 
Endomerial cancer
Endomerial cancer Endomerial cancer
Endomerial cancer paviarun
 
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...Eneutron
 

What's hot (19)

Uterine cancer
Uterine cancerUterine cancer
Uterine cancer
 
4 u1.0-b978-1-4160-6643-9..00193-4..docpdf
4 u1.0-b978-1-4160-6643-9..00193-4..docpdf4 u1.0-b978-1-4160-6643-9..00193-4..docpdf
4 u1.0-b978-1-4160-6643-9..00193-4..docpdf
 
He 210 ol power point presentation #1
He 210 ol power point presentation #1He 210 ol power point presentation #1
He 210 ol power point presentation #1
 
Vulvar cancer
Vulvar cancerVulvar cancer
Vulvar cancer
 
Phyllodes Tumors: What is the Best Therapeutic Option?_ Crimson Publishers
Phyllodes Tumors: What is the Best Therapeutic Option?_ Crimson PublishersPhyllodes Tumors: What is the Best Therapeutic Option?_ Crimson Publishers
Phyllodes Tumors: What is the Best Therapeutic Option?_ Crimson Publishers
 
Nulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies editedNulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies edited
 
Endometrioid adenocarcinoma
Endometrioid adenocarcinomaEndometrioid adenocarcinoma
Endometrioid adenocarcinoma
 
Endometrial cancer
Endometrial cancerEndometrial cancer
Endometrial cancer
 
Malignant Ovarian Tumors Dr H.K.Cheema Professor OBG,PIMS, Jalandhar
Malignant Ovarian Tumors  Dr H.K.Cheema Professor OBG,PIMS, JalandharMalignant Ovarian Tumors  Dr H.K.Cheema Professor OBG,PIMS, Jalandhar
Malignant Ovarian Tumors Dr H.K.Cheema Professor OBG,PIMS, Jalandhar
 
Clinical Gynecologic Oncology, Di saia 9780323074193_ sample chapter
Clinical Gynecologic Oncology, Di saia 9780323074193_ sample chapterClinical Gynecologic Oncology, Di saia 9780323074193_ sample chapter
Clinical Gynecologic Oncology, Di saia 9780323074193_ sample chapter
 
Surgical Oncology
Surgical OncologySurgical Oncology
Surgical Oncology
 
Lecture 1 Pathology: Cervix pdf
Lecture  1 Pathology: Cervix pdfLecture  1 Pathology: Cervix pdf
Lecture 1 Pathology: Cervix pdf
 
Ca cervix
Ca cervix  Ca cervix
Ca cervix
 
UTERINE LEIOMYOSARCOMA
UTERINE LEIOMYOSARCOMAUTERINE LEIOMYOSARCOMA
UTERINE LEIOMYOSARCOMA
 
carcinoma cervix -update
carcinoma cervix -updatecarcinoma cervix -update
carcinoma cervix -update
 
Endo ca
Endo caEndo ca
Endo ca
 
Cervical Carcinoma
Cervical CarcinomaCervical Carcinoma
Cervical Carcinoma
 
Endomerial cancer
Endomerial cancer Endomerial cancer
Endomerial cancer
 
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
Oncology epidemiology. Malignant tumor formation. Fight against cancer, dispe...
 

Similar to FDG PET/CT Utility in Gynecologic Malignancies

Surgical management of adrenal mets introduction
Surgical management of adrenal mets introductionSurgical management of adrenal mets introduction
Surgical management of adrenal mets introductionJJSancho
 
Common gynaecological carcinom final2
Common gynaecological carcinom final2Common gynaecological carcinom final2
Common gynaecological carcinom final2Lee Jhung
 
Gynaecology Thicknend Endometrium leceture 3 part 2.pptx
Gynaecology Thicknend Endometrium leceture 3 part 2.pptxGynaecology Thicknend Endometrium leceture 3 part 2.pptx
Gynaecology Thicknend Endometrium leceture 3 part 2.pptxRadiantree
 
Carcinoma of breast: What should be done?
Carcinoma of breast: What should be done?Carcinoma of breast: What should be done?
Carcinoma of breast: What should be done?KETAN VAGHOLKAR
 
Benign & precancerous tumors of female genital organs
Benign & precancerous tumors of female genital organsBenign & precancerous tumors of female genital organs
Benign & precancerous tumors of female genital organsberbets
 
invasise Cervical carcinoma
invasise Cervical carcinomainvasise Cervical carcinoma
invasise Cervical carcinomaAisha Nazeer
 
An apporach to ovarian pathology
An apporach to ovarian pathologyAn apporach to ovarian pathology
An apporach to ovarian pathologyMilan Silwal
 
Management of presarcral tumors
Management of presarcral tumorsManagement of presarcral tumors
Management of presarcral tumorsJawad Ahmad
 
Benign neoplasms of the genital 2.pdf
Benign neoplasms of the genital 2.pdfBenign neoplasms of the genital 2.pdf
Benign neoplasms of the genital 2.pdfugonnanwoke
 
Management of ovarian cyst.pdf
Management of ovarian cyst.pdfManagement of ovarian cyst.pdf
Management of ovarian cyst.pdfssuser2920f71
 
cervical and ovarian cancer study: a review
cervical and ovarian cancer study: a reviewcervical and ovarian cancer study: a review
cervical and ovarian cancer study: a reviewAYODEJI BLESSING AJILEYE
 
malignant ovarian tumour
malignant ovarian tumourmalignant ovarian tumour
malignant ovarian tumourAisha Nazeer
 

Similar to FDG PET/CT Utility in Gynecologic Malignancies (20)

Surgical management of adrenal mets introduction
Surgical management of adrenal mets introductionSurgical management of adrenal mets introduction
Surgical management of adrenal mets introduction
 
Common gynaecological carcinom final2
Common gynaecological carcinom final2Common gynaecological carcinom final2
Common gynaecological carcinom final2
 
Gynaecology Thicknend Endometrium leceture 3 part 2.pptx
Gynaecology Thicknend Endometrium leceture 3 part 2.pptxGynaecology Thicknend Endometrium leceture 3 part 2.pptx
Gynaecology Thicknend Endometrium leceture 3 part 2.pptx
 
Carcinoma of breast: What should be done?
Carcinoma of breast: What should be done?Carcinoma of breast: What should be done?
Carcinoma of breast: What should be done?
 
Benign & precancerous tumors of female genital organs
Benign & precancerous tumors of female genital organsBenign & precancerous tumors of female genital organs
Benign & precancerous tumors of female genital organs
 
invasise Cervical carcinoma
invasise Cervical carcinomainvasise Cervical carcinoma
invasise Cervical carcinoma
 
An apporach to ovarian pathology
An apporach to ovarian pathologyAn apporach to ovarian pathology
An apporach to ovarian pathology
 
Ca endometrium
Ca endometriumCa endometrium
Ca endometrium
 
Management of presarcral tumors
Management of presarcral tumorsManagement of presarcral tumors
Management of presarcral tumors
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Benign neoplasms of the genital 2.pdf
Benign neoplasms of the genital 2.pdfBenign neoplasms of the genital 2.pdf
Benign neoplasms of the genital 2.pdf
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
Carcinoma vagina
Carcinoma vaginaCarcinoma vagina
Carcinoma vagina
 
Management of ovarian cyst.pdf
Management of ovarian cyst.pdfManagement of ovarian cyst.pdf
Management of ovarian cyst.pdf
 
Menorrhagia
MenorrhagiaMenorrhagia
Menorrhagia
 
cervical and ovarian cancer study: a review
cervical and ovarian cancer study: a reviewcervical and ovarian cancer study: a review
cervical and ovarian cancer study: a review
 
Cin&cancer cervix undergraduate
Cin&cancer cervix undergraduateCin&cancer cervix undergraduate
Cin&cancer cervix undergraduate
 
malignant ovarian tumour
malignant ovarian tumourmalignant ovarian tumour
malignant ovarian tumour
 
ca cervix.pdf
ca cervix.pdfca cervix.pdf
ca cervix.pdf
 

FDG PET/CT Utility in Gynecologic Malignancies

  • 1. FDG PET/CT Utility in Gynecologic Malignancies: A comprehensive review of anatomy, pathways of metastatic spread and scan findings Nicholas Plaxton, MD1 , Aruna Polsani, MD1, Raghuveer Halkar, MD1, Karen Godette, MD1 , Barron, Bruce, MD1,2 1Emory University School of Medicine, 2 Atlanta Veterans Affairs Medical Center LEARNING OBJECTIVES PELVIC ANATOMY CERVICAL OVARIAN ENDOMETRIAL VAGINAL Uterine fundus • 150,000 Deaths annually • 2nd most common gynecological cancer 1. Pictorial review of clinical features of major • Most common gynecological cancer • Cervical cancer extension or recurrence into Fallopian tube  4000 in US • Most common death from gynecologic cancer gynecologic cancers including cervical, • 142,000 women per year the vagina is most common tumor ovarian, endometrial, vaginal, and vulvar Infundibulum Fimbria  11,000 new cases in US • 22,000 new cases and 14,000 deaths in US • 4TH most common malignancy in US women • Primary vaginal cancer is less than 3% of all Ovary • PET/CT is more accurate in assessing nodal • Nonspecific symptoms – bloating, distention malignancies and demonstrate the role of Uterine Body • Most cases in post menopause gynecological malignancies Ascending branch of uterine artery spread than CT and MRI (sensitivity 89% vs 39%) • 75 % present with stage III or IV disease FDG PET/CT. Internal iliac • Highest incidence in 7TH decade of life • Squamous type (HPV , 60 – 80 yrs) artery • SUV negatively correlates to treatment response • Residual tumor > 2cm survival of 12-16 months • Abnormal uterine bleeding common symptom • Adenocarcinoma type ( DES use, 12 – 30 yrs) Cervix Uterine artery External Os • Positive PET has positive predictive value of 90% • Tumor < 2 cm survival is 40-45 months 2. Illustrate and correlate anatomic and Vaginal branch of uterine artery • 5 year survival 80% • Lymphatic spread in distal 1/3 to inguinal nodes Vaginal canal • PET has high rate of false negatives • Debulking surgery is mainstay of treatment conventional imaging features of • Dependent on stage, myometrial involvement • Lymphatic spread in proximal 2/3 to pelvic and • Limited sensitivity in early stage IA and IIA • Preoperative imaging achieves optimal debulking gynecologic malignancies. and histological type para-arotic nodes (PALN) • Try to minimize urine FDG activity (Foley, voiding) • PET improves accuracy in staging Coronal Illustration • Poor prognosis in advanced or recurrent disease • Primary spread of tumor via lymph node paths • Staging concordant with clinical pathology in 69% 3. Demonstrate the integration of FIGO 1. obturator, internal iliac, external iliac, and common iliac • Lymphatic spread to pelvic or para-arotic nodes scoring and treatment planning to improve 2. direct to common iliac for PET vs. 53% for CT • Hematogenous spread to lung, liver, bones or accuracy of staging. 3. common iliac, pre-sacral and para-arotic • Mucinous type represents 12-15% of ovarian vagina Perimetrium • Inguinal /axillary nodes reactive in HIV, not mets cancers and usual is not FDG avid INTRODUCTION Myometrium Rectouterine pouch • Liver metastasis in a third of recurrent disease • Ovarian cancer tends to spread via peritoneal Vaginal metastasis before and after treatment Cervix of Douglas In the United States in 2007,* 80,976 women Fundus Endometrium Body were diagnosed with gynecologic cancer, and 27,739 succumbed to the disease. Our Vesicouterine pouch of Meiring objective was to review the five major gynecologic cancers (cervical, ovarian, Primary uterine cancer T2 Weighted MRI pelvis Virchow’s Node uterine, vaginal, and vulvar) and demonstrate the role of FDG PET/CT in diagnosis, surveillance, FIGO staging and treatment Cervical cancer with pyometra Bilateral Ovarian Cancer Vaginal melanoma Vaginal cancer strategy. We selected FDG PET/CT cases done at Emory University with strong key Right ovary with cysts Left ovary VULVAR Internal iliac artery • 4% all women genital cancers originate in vulva Right internal representative findings for each of these iliac artery Left iliacus muscle gynecological cancers for presentation. • 2/100,000 women per year Psoas muscle Endometrial cancer with malignant effusion • 40-60% in premenopause associated with HPV Understanding of key findings in gynecological malignancies is crucial for early • HPV negative more common in post-menopausal diagnosis, treatment strategy and assessment • Growth and infiltration with direct involvement of of treatment response. the vagina, urethra, perineum, and /or anus Upper pelvis axial CT with contrast • Lymphatic spread to inguinal and femoral nodes CONTACT Sister Mary Peritoneal Caking • 1-7% involve Bartholin’s gland Solitary Cervical cancer with Joseph node • FIGO changes based on invasion and size and Nicholas A. Plaxton M.D. hepatic obstructed os the number of involved lymph nodes Depart of Radiology and Imaging Sciences External iliac artery metastasis • FDG PET sens and spec of 80 and 90% Division of Nuclear Medicine • More accurate in detecting extranodal metastases Round ligaments Email: nickplaxton@emory.edu Planning Target Volume for Phone: 404 712 4868 External iliac vein radiation treatment Bladder References and FIGO classification available Uterus upon request. Thanks to Eric Jablonowski for illustration. Lower pelvis axial CT with contrast Poster Design & Printing by Genigraphics® - 800.790.4001 Cervical cancer with HIV and lymphadenapathy Peritoneal Implants Endometrial cancer with multiple metastases Vulvar cancer